Back to Results
First PageMeta Content
Janssen Pharmaceutica / Piperazines / Organochlorides / Antifungals / Dioxolanes / Itraconazole / Onychomycosis / MedWatch / Adverse effect / Organic chemistry / Chemistry / Medicine


IMPORTANT SAFETY INFORMATION May, 2001 Dear Health Care Professional, Janssen Pharmaceutica Products, L.P. and Ortho Biotech Products, L.P. would like to inform you about revised labeling for SPORANOX® (itraconazole) Ca
Add to Reading List

Open Document

File Size: 50,40 KB

Share Result on Facebook

City

Rockville / TITUSVILLE / /

Company

Janssen Pharmaceutica Products L.P. / Medical Affairs Janssen Pharmaceutica Products L.P. / 2001 Dear Health Care Professional / North America Ortho Biotech Products L.P. / Ortho Biotech Products L.P. / /

/

MedicalCondition

congestive heart failure / ventricular dysfunction / onychomycosis / systemic fungal infection / pulmonary edema / /

Organization

FDA / POST OFFICE / /

Person

Martine J. George / Christina Farup / /

/

Position

Vice President / Clinical Affairs / Executive Director / Director / Outcomes Research and Medical Informatics Acting Vice President / /

Product

Tikosyn / SPORANOX / itraconazole / erythromycin / /

ProvinceOrState

New Jersey / Maryland / /

URL

www.fda.gov/medwatch / http /

SocialTag